Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Villarreal

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Cytotherapy|March 20, 2014
Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trialConsuelo Mancías-Guerra, Alma Rosa Marroquín-Escamilla, Oscar González-Llano, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 6, 2021
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitorsMiguel Escobar, James Luck, Yevhenii Averianov, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 27, 2022
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitorsSteven W Pipe, Cédric Hermans, Meera Chitlur, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 7, 2020
Prevalence of inhibitors and clinical characteristics in patients with haemophilia in a middle-income Latin American countryLaura Villarreal-Martínez, Jaime García-Chávez, Berenice Sánchez-Jara, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Cytotherapy|March 20, 2014
Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trialConsuelo Mancías-Guerra, Alma Rosa Marroquín-Escamilla, Oscar González-Llano, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 6, 2021
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitorsMiguel Escobar, James Luck, Yevhenii Averianov, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 27, 2022
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitorsSteven W Pipe, Cédric Hermans, Meera Chitlur, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 7, 2020
Prevalence of inhibitors and clinical characteristics in patients with haemophilia in a middle-income Latin American countryLaura Villarreal-Martínez, Jaime García-Chávez, Berenice Sánchez-Jara, et al.
Pageof 7